NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / December 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 30, 2024 and November 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 3, 2025.
SAN FRANCISCO, CA / ACCESSWIRE / December 27, 2024 / Shares of ASP Isotopes Inc. (NASDAQ:ASPI) have continue their downward spiral falling 16% over the past five days, despite the company having issued a rebuttal to a scathing report from activist short-seller Fuzzy Panda Research. The stock price trades at $4.52 per share, marking a 40% decline since the release of the short seller report late last month.
NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK CITY, NY / ACCESSWIRE / December 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ASP Isotopes securities between October 30, 2024 and November 26, 2024, both dates inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Pomerantz LLP announces that a class action lawsuit has been filed against ASP Isotopes Inc. ("ASPI" or the "Company") (NASDAQ:ASPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.